Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons

Journal of Neurochemistry

Volumn 89, Issue 2, 2004, Pages 474-483

  Sasaki, Takashi ^a   Kotera, Jun ^a   Omori, Kenji ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Cyclic AMP; Cyclic AMP response element binding protein; Dopamine; Phosphodiesterase 7B promoter; Striatum

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 BROMO CYCLIC AMP; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; FORSKOLIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHODIESTERASE;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL CULTURE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ELECTROPHORETIC MOBILITY; GENE DELETION; GENE MUTATION; GENE SEQUENCE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRIATE CORTEX; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; 8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ENZYME INHIBITORS; FORSKOLIN; ISOENZYMES; MOLECULAR SEQUENCE DATA; NEOSTRIATUM; NEURONS; PROMOTER REGIONS (GENETICS); RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

ANIMALIA;

EID: 1942423571     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02354.x     Document Type: Article

References (42)

1. Bibb J. A., Chen J., Taylor J. R. et al. (2001) Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410, 376-380.
2. Cole D. G., Kobierski L. A., Konradi C. and Hyman S. E. (1994) 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Proc. Natl Acad. Sci. USA 91, 9631-9635.
3. Conti M. and Jin S. L. (1999) The molecular biology of cyclic nucleotide phosphodiesterases. Prog. Nucl. Acid Res. Mol. Biol. 63, 1-38.
4. D'Sa C., Tolbert L. M., Conti M. and Duman R. S. (2002) Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons. J. Neurochem. 81, 745-757.
5. Erdogan S. and Houslay M. D. (1997) Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant. Biochem. J. 321, 165-175.
6. Francis S. H., Turko I. V. and Corbin J. D. (2001) Cyclic nucleotide phosphodiesterases: relating structure and function. Prog. Nucl. Acid Res. Mol. Biol. 65, 1-52.
7. Frumkin A., Rangini Z., Ben-Yehuda A., Gruenbaum Y. and Fainsod A. (1991) A chicken caudal homologue, CHox-cad, is expressed in the epiblast with posterior localization and in the early endodermal lineage. Development 112, 207-219.
8. Fujishige K., Kotera J., Michibata H., Yuasa K., Takebayashi S., Okumura K. and Omori K. (1999) Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A). J. Biol. Chem. 274, 18438-18445.
9. Fujishige K., Kotera J., Yuasa K. and Omori K. (2000) The human phosphodiesterase PDE10A gene genomic organization and evolutionary relatedness with other PDEs containing GAFdomains. Eur. J. Biochem. 267, 5943-5951.
10. Glavas N. A., Ostenson C., Schaefer J. B., Vasta V. and Beavo J. A. (2001) T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3. Proc. Natl Acad. Sci. USA 98, 6319-6324.
11. Graveland G. A., Williams R. S. and DiFiglia M. (1985) Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 227, 770-773.
12. Greengard P., Allen P. B. and Nairn A. C. (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23, 435-447.
13. Heinemeyer T., Wingender E., Reuter I. et al. (1998) Databases on transcriptional regulation: TRANSFAC, TRRD, and COMPEL. Nucl. Acids Res. 26, 364-370.
14. Hetman J. M., Soderling S. H., Glavas N. A. and Beavo J. A. (2000) Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase. Proc. Natl Acad. Sci. USA 97, 472-476.
15. Kasuya J., Liang S. J., Goko H., Park S. H., Kato K., Xu Z. D., Hockman S., Manganiello V. C. and Fujita-Yamaguchi Y. (2000) Cardiac type cGMP-inhibited phosphodiesterase (PDE3A) gene structure: similarity and difference to adipocyte type PDE3B gene. Biochem. Biophys. Res. Commun. 268, 827-834.
16. Kebabian J. W. and Calne D. B. (1979) Multiple receptors for dopamine. Nature 277, 93-96.
17. Kelz M. B. and Nestler E. J. (2000) ΔFosB: a molecular switch underlying long-term neural plasticity. Curr. Opin. Neurol. 13, 715-720.
18. Kish S. J., Shannak K. and Hornykiewicz O. (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N. Engl. J. Med. 318, 876-880.
19. Konradi C., Cole R. L., Heckers S. and Hyman S. E. (1994) Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci. 14, 5623-5634.
20. Kotera J., Sasaki T., Kobayashi T., Fujishige K., Yamashita Y. and Omori K. (2004) Subcellular localization of cyclic nucleotide phosphodiesterase type 10A (PDE10A) variants, and alteration of the localization by PKA-dependent phosphorylation. J. Biol. Chem. 299, 4366-4575.
21. Lee W., Haslinger A., Karin M. and Tjian R. (1987) Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature 325, 368-372.
22. Le Jeune I. R., Shepherd M., Van Heeke G., Houslay M. D. and Hall I. P. (2002) Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter. J. Biol. Chem. 277, 35 980-35 989.
23. Li L., Yee C. and Beavo J. A. (1999) CD3- and CD28-dependent induction of PDE7 required for T cell activation. Science 283, 848-851.
24. Lin C. S., Chow S., Lau A., Tu R. and Lue T. F. (2001a) Identification and regulation of human PDE5A gene promoter. Biochem. Biophys. Res. Commun. 280, 684-692.
25. Lin C. S., Chow S., Lau A., Tu R. and Lue T. F. (2001b) Regulation of human PDE5A2 intronic promoter by cAMP and cGMP: identification of a critical Sp1-binding site. Biochem. Biophys. Res. Commun. 280, 693-699.
26. Liu H. and Maurice D. H. (1998) Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP. Br. J. Pharmacol. 125, 1501-1510.
27. Lobban M., Shakur Y., Beattie J. and Houslay M. D. (1994) Identification of two splice variant forms of type-IVB cyclic AMP phosphodiesterase, DPD (rPDE-IVB1) and PDE-4 (rPDE-IVB2) in brain: selective localization in membrane and cytosolic compartments and differential expression in various brain regions. Biochem. J. 304, 399-406.
28. Manning C. D., McLaughlin M. M., Livi G. P., Cieslinski L. B., Torphy T. J. and Barnette M. S. (1996) Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B. J. Pharmacol. Exp. Ther. 276, 810-818.
29. Miro X., Perez-Torres S., Artigas F., Puigdomenech P., Palacios J. M. and Mengod G. (2002) Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology 43, 1148-1157.
30. Montminy M. (1997) Transcriptional regulation by cyclic AMP. Annu. Rev. Biochem. 66, 807-822.
31. Montminy M. R. and Bilezikjian L. M. (1987) Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 328, 175-178.
32. Morris J. F., Hromas R., Rauscher F. J. 3rd (1994) Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core. Mol. Cell Biol. 14, 1786-1795.
33. Obeso J. A., Rodriguez M. C. and DeLong M. R. (1997) Basal ganglia pathophysiology. A critical review. Adv. Neurol. 74, 3-18.
34. Polli J. W. and Kincaid R. L. (1994) Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation. J. Neurosci. 14, 1251-1261.
35. Rena G., Begg F., Ross A., MacKenzie C., McPhee I., Campbell L., Huston E., Sullivan M. and Houslay M. D. (2001) Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic AMP-specific phosphodiesterase PDE4A10. Mol. Pharmacol. 59, 996-1011.
36. Sasaki T., Kotera J., Yuasa K. and Omori K. (2000) Identification of human PDE7B, a cAMP-specific phosphodiesterase. Biochem. Biophys. Res. Commun. 271, 575-583.
37. Sasaki T., Kotera J. and Omori K. (2002) Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation. Biochem. J. 361, 211-220.
38. Sinclair A. H., Berta P., Palmer M. S., Hawkins J. R., Griffiths B. L., Smith M. J., Foster J. W., Frischauf A. M., Lovell-Badge R. and Goodfellow P. N. (1990) A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346, 240-244.
39. Snyder G. L., Fienberg A. A., Huganir R. L. and Greengard P. (1998) A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa) /protein phosphatase-1pathway regulates dephosphorylation of the NMDA receptor. J. Neurosci. 18, 10 297-10 303.
40. Soderling S. H. and Beavo J. A. (2000) Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr. Opin. Cell Biol. 12, 174-179.
41. Takahashi M., Terwilliger R., Lane C., Mezes P. S., Conti M. and Duman R. S. (1999) Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms. J. Neurosci. 19, 610-618.
42. Wang L. Y., Salter M. W. and MacDonald J. F. (1991) Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases. Science 253, 1132-1135.